Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis
Clinical trial NCT01833754 · COMPLETED
Trial details
- NCT number
- NCT01833754
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-22
- Primary completion
- 2014-02-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.